SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-11-021284
Filing Date
2011-04-11
Accepted
2011-04-11 16:01:23
Documents
3
Period of Report
2011-04-05
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT v218105_8k.htm 8-K 42675
2 AMENDED AND RESTATED BYLAWS OF NEKTAR THERAPEUTICS v218105_ex3-1.htm EX-3.1 145692
3 NEKTAR THERAPEUTICS AMENDED AND RESTATED CHANGE OF CONTROL SEVERANCE BENEFIT PL v218105_ex10-1.htm EX-10.1 156185
  Complete submission text file 0001144204-11-021284.txt   345937
Mailing Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158
Business Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158 4154825300
NEKTAR THERAPEUTICS (Filer) CIK: 0000906709 (see all company filings)

IRS No.: 943134940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-24006 | Film No.: 11752726
SIC: 2834 Pharmaceutical Preparations